Find out how Supreme Pharmaceuticals is leveraging growth in the cannabis market
At the recent Toronto Capital Conference, SmallCapPower spoke with John Fowler, President and CEO of Supreme Pharmaceuticals Inc. (CSE:SL), a leading supplier of affordable cannabis. Supreme’s primary asset is 7ACRES, one of the biggest marijuana cultivators in Canada. In this interview Mr. Fowler tells us about why the Company chose to pursue a B2B approach to distribution rather than making sales to individual patients, and why the B2B model is beneficial to users.
Related: Supreme Pharmaceuticals (CSE:SL) is Set to Be a Player in the Marijuana Space
For more exclusive coverage from Toronto Capital Conference click here >>
